Dear Investor,
Last month, super-investor Dylan Jovine showed investors easy 144% profits when Array Biopharma was taken over on the 17th...
On January 4th, 2019 he recommended Loxo Oncology... 3 days later it was taken over for a super-fast 71% gain…
On October 19th of 2018 he recommended Pacific Biosciences... 4 days later it was taken over for a quick 72% gain…
On October 1st of 2018, he recommended shares of Tesaro... 63 days later it was taken over for an easy 91% profit .
On September 28, 2018 he recommended American Railcar... 16 days later it was taken over for a fast 51% gain...
This guy is an absolute genius. The question now is, what's Mr. Jovine's next move?
He just recommended another tiny biotech stock that just won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body.
The age-old investor's wisdom to "follow the smart money" has never been more appropriate. You now have the opportunity - on any level you choose - to put your money right next to money that "always wins."
The Best Idea You've Heard All Year
My name is Brad Sullivan, and I'm the Publisher at Behind the Markets.
By the time Dylan became disgusted with Wall Street and sold his brokerage firm at age 30, he'd made millions. I don't bring this up to brag -- but to drive home the point I'm about to make:
If I woke up tomorrow morning and found that I literally had only one measly dollar left to my name ... I would be 100% confident that I could make back my millions in relatively short order.
And how would I start? I'd hitch my wagon to Dylan Jovine and invest that dollar in the stock that he's drooling over right now.
I'm convinced that this will be the best stock idea you've heard all year. This is a recommendation that can get taken over any day – and make you 300% richer in the next 6 months.
You'll discover why …
- The Nobel Prize Committee is calling it "The Holy Grail of Medicine"
- The Wall Street Journal reports the company is "transforming medicine."
- 60 Minutes reports the company is "revolutionizing the search for new drugs."
Never before has so much money invested in a new treatment so quickly.
And because of that, it's going to create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.
Investor's Business Daily estimates the market is worth at least $75 billion market.
But right now, its stock price is just a tiny fraction of that size.
That's if the company doesn't get taken over for fast 300% gains first.
Sincerely,
Brad Sullivan
Publisher
Behind the Markets
This email is a paid advertisement. It is for a product or service that is not offered, recommended or endorsed by OptionPub and neither the company nor its affiliates bear responsibility or control over the content of the advertisement and the product or service offered. There is a very high degree of risk involved in trading. Past results are not indicative of future returns. OptionPub and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for any trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. By downloading this book your information may be shared with our educational partners. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of OptionPub may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.
This email was sent to phanhoa1821960.trader@blogger.com by OptionPub
No comments:
Post a Comment